Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,646
Total Claims
$1.5M
Drug Cost
2,888
Beneficiaries
$531
Cost/Patient
Risk Score Breakdown 30/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-96%
Opioid rate vs peers
0.2% vs 3.8% avg
-55%
Cost per patient vs peers
$531 vs $1,174 avg
+28%
Brand preference vs peers
11.3% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.2%
Opioid Rate
38
Opioid Claims
$952
Opioid Cost
28.9%
Long-Acting Rate
Brand vs Generic
Brand: 2,546 claims · $1.0M
Generic: 19,930 claims · $492K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 471 | $315K |
| Rivaroxaban | 87 | $70K |
| Dulaglutide | 59 | $68K |
| Sitagliptin Phosphate | 55 | $45K |
| Empagliflozin | 45 | $38K |
| Fluticasone/Umeclidin/Vilanter | 41 | $36K |
| Levothyroxine Sodium | 1,459 | $26K |
| Tiotropium Bromide | 32 | $25K |
| Atorvastatin Calcium | 1,362 | $23K |
| Mirabegron | 34 | $22K |
| Sacubitril/Valsartan | 36 | $21K |
| Insulin Glargine,hum.Rec.Anlog | 61 | $19K |
| Umeclidinium Brm/Vilanterol Tr | 38 | $18K |
| Dapagliflozin Propanediol | 25 | $17K |
| Fluticasone Propion/Salmeterol | 69 | $16K |
Prescribing Profile
Patient Profile
80
Avg Age
65%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About